Medicine composition for treating phlebitis caused by amiodarone vein application
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technique for phlebitis, amiodarone, applied in the field of medicine
Inactive Publication Date: 2016-04-06
JINAN XINSHIDAI MEDICINE SCI & TECH
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] For phlebitis caused by intravenous application of amiodarone, there is no specific drug with good curative effect
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0032] A pharmaceutical composition for treating phlebitis caused by intravenous application of amiodarone, the weight ratio of each raw material is as follows:
[0033] 60g of cattail, 60g of Chlorophytum, 60g of apricot leaves, 60g of radish, 60g of lotus, 60g of iron fern chicken, 60g of water fennel, 60g of fine sand cordyceps, 60g of iron horsewhip, and 60g of coreopsis.
[0034] Preparation and use method: mix the traditional Chinese medicines of the medicine of the present invention, grind them into fine powder, and set aside. When using, take an appropriate amount of fine powder, mix thoroughly with water, white wine, tea, vinegar, egg white, vaseline, sesame oil, tea seed oil or glycerin and apply to the affected area.
Embodiment 2
[0036] A pharmaceutical composition for treating phlebitis caused by intravenous application of amiodarone, the weight ratio of each raw material is as follows:
[0037] Pukui seeds 50g, Chlorophytum 70g, Apricot Leaf Fangfeng 50g, Shiluo 70g, Dengtai lotus 50g, Iron fern chicken 70g, Water fennel 50g, Cordyceps 70g, Iron horse whip 50g, Coreopsis 70g.
[0038] The preparation and use methods are the same as in Example 1.
Embodiment 3
[0040] A pharmaceutical composition for treating phlebitis caused by intravenous application of amiodarone, the weight ratio of each raw material is as follows:
[0041] Pukui 70g, Chlorophytum 50g, Apricot Leaf Fangfeng 70g, Shiluo 50g, Dengtai Lian 70g, Iron Fern Chicken 50g, Water Fennel 70g, Fine Sand Cordyceps 50g, Iron Horsewhip 70g, Lineleaf Coreopsis 50g.
[0042] The preparation and use methods are the same as in Example 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention belongs to the technical field of medicine and particularly relates to a medicine composition for treating phlebitis caused by amiodarone vein application. The medicine composition is prepared from, by weight, 4-6 parts of Chinese fan palms, 4-6 parts of fewflower lysionotus herbs, 4-6 parts of herba pimpinellae, 4-6 parts of pentasachme caudatum, 4-6 parts of Arisaema bockii, 4-6 parts of nude pronephrium rhizome, 4-6 parts of phellandrene, 4-6 parts of roots of perny germander, 4-6 parts of lespedeza pilosa and 4-6 parts of coreopsis lanceolata. The medicines are used in a cooperation mode, and the medicine composition has the effects of clearing away heat and toxic materials, promoting blood circulation to remove meridian obstruction, dispersing blood stasis, eliminating stagnation, and relieving swelling and pain, is used for treating phlebitis caused by amiodarone vein application, and has the advantages of being high in curative rate and total effective rate.
Description
technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a pharmaceutical composition for treating phlebitis caused by intravenous application of amiodarone. Background technique [0002] Phlebitis is an infusion reaction caused by the infusion of high-concentration, hyperosmolar, and toxic drugs during the infusion process. It can also be caused by infusion equipment, improper operation of liquid preparation, and repeated punctures. Amiodarone is a broad-spectrum antiarrhythmic drug. It is a common drug for the treatment of supraventricular arrhythmia and ventricular arrhythmia. It has the advantages of wide application, good curative effect, and small side effects. Applied to emergency and critical diseases such as supraventricular tachycardia and sustained ventricular tachycardia. However, because amiodarone intravenous preparations are highly irritating to blood vessels, severe phlebitis usually occurs after continuo...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more